SeaStar Medical announced the appointment of Michael Messinger as Chief Financial Officer.
Michael Messinger brings over 25 years of industry experience as a seasoned healthcare executive to SeaStar Medical.
His financial expertise and strategic healthcare background aim to support the company in its commercial operations and future opportunities.
Experience and Expertise
Michael Messinger has over two decades of experience in financing and accounting for drug discovery and development organizations.
Leadership Background
He has held senior financial roles at reputable organizations and served as CFO of ContraFect Corporation, leading the company through significant financial milestones.
Strategic Vision
Mr. Messinger's appointment aligns with SeaStar Medical's mission to expand their innovative SCD therapy and impact patients facing organ failure.
- The appointment of Michael Messinger as CFO signals SeaStar Medical's strategic focus on financial growth and operational efficiency.
- His track record in leading organizations through financing rounds and strategic partnerships positions SeaStar Medical for future commercial success.
The addition of Michael Messinger as CFO positions SeaStar Medical for continued growth and success in transforming treatments for critically ill patients.